ETF STRATEGIES
Improve Your ETF Trading
Receive Alerts
Free

For One Week!
Stock PowerRatings
Use PowerRatings every day to find the stocks for tomorrow to focus on and the ones to avoid. Sign Up Now >>

ETF PowerRatings
Use PowerRatings to find the ETFS to focus on to build your portfolio for ETF gains.
Sign Up Now >>

Gary Kaltbaum Intraday Breaking Setups
Let Gary Kaltbaum send you timely emails to alert you when breakouts occur.
Sign Up Now >>

Kevin Haggerty's Professional Trading Service
Every day receive the best plan of attack for the next day's trading directly from professional trader Kevin Haggerty.
Sign Up Now >>
awards
TradingMarkets AS SEEN ON...
Yahoo! Finance (content partner)
Forbes.com (content partner)
AOL Money (content partner)
CNBC
Fox Business News
Bloomberg TV
Wall Street Journal
MarketWatch
Fortune
New York Times
Stocks and Commodities
Active Trader Magazine
Los Angeles Times
Futures Magazine
Barrons
Reuters
SFO Magazine
Investor's Edge
E*Trade Radio
Bloomberg Markets Magazine
Chicago Mercantile Exchange
Forbes.com
SFO
Registered Rep
FXstreet.com

  Results matching symbol: GSK.L

(RTTNews) - Biotechnology firm Human Genome Sciences Inc. (HGSI) said Monday that it will reveal the progress made towards the commercialization of late-stage products and its priority goals set for 2 Read More >>
(RTTNews) - Financial advisory and asset management firm Lazard Ltd. (LAZ | Quote | Chart | News | PowerRating) Tuesday announced the appointment of Kenneth Jacobs as Chairman and Chief Executive Officer, succeeding Bruce Wasserstein, who passed away unexpectedly last month. Jacobs, formerly Read More >>
(RTTNews) - French drug company Sanofi-Aventis Inc. (SNY | Quote | Chart | News | PowerRating) Friday reported higher third-quarter profit, driven by strong sales in its Pharmaceuticals, Human Vaccines and Generics businesses. The company also raised its adjusted earnings per share growth fo Read More >>
(RTTNews) - Pharmaceutical giant GlaxoSmithKline plc (GSK, GSK.L) on Wednesday reported an increase in third-quarter profit, as sales grew 15% from last year, helped by favorable currency movements as well as demand for its flu products. The company said it expects further growth in the fourth quar Read More >>
(RTTNews) - Friday, British pharma giant, GlaxoSmithKline (GSK, GSK.L) reported that the U.S. Food and Drug Administration or FDA approved its cervical cancer vaccine Cervarix. The vaccine is authorised for treatment of cervical pre cancers and cancers in teenage girls and women caused by two types Read More >>
(RTTNews) - British pharma giant GlaxoSmithKline Plc (GSK ,GSK.L), Wednesday, reported a rise in profit for the second quarter, aided by strong performances in emerging markets and increased sales from new products and flu drug Relenza. Looking ahead, the drug maker said it expects improvement in Read More >>
(RTTNews) - Healthcare giant Merck & Co. Inc. (MRK | Quote | Chart | News | PowerRating) Tuesday reported a 12% decline in second-quarter profit, hurt mainly by lower revenues as well as merger and restructuring costs. On an adjusted basis, earnings per share came in above analysts forecast Read More >>

Merck: Q2 Earnings Preview

December 29, 2009
(RTTNews) - Healthcare giant Merck & Co. Inc. (MRK | Quote | Chart | News | PowerRating) is scheduled to announce its second-quarter results before market opens Tuesday. The companys earnings and revenues for the quarter are expected to be lower than last year reflecting adverse market cond Read More >>
(RTTNews) - British pharma major GlaxoSmithKline Plc (GSK, GSK.L), Wednesday, reported a decline in profit for the first quarter, hurt mainly by restructuring charges and a 22% decline in US pharmaceutical sales at constant currencies, which was negatively impacted by generic competition.First-quar Read More >>
(RTTNews) - Healthcare giant Merck & Co. Inc. (MRK | Quote | Chart | News | PowerRating), Tuesday, reported a 56% decline in its first-quarter profit, as many of its products suffered sales declines amid the difficult global economy. On a non-GAAP basis, earnings per share came in below anal Read More >>
(RTTNews) - British drug major GlaxoSmithKline Plc (GSK, GSK.L), Monday, said it signed an agreement to acquire US-based privately held dermatology company Stiefel Laboratories Inc. in a deal valued at up to $3.6 billion, including $2.9 billion in cash, thus to create a new world-leading specialist Read More >>
(RTTNews) - Sunday, according to the Wall Street Journal, British pharma giant GlaxoSmithKline plc (GSK, GSK.L) is close to acquiring privately-held Stiefel Laboratories, Inc. for about $3 billion. The companies are in late stage talks, with an announcement on the deal expected on Monday, although Read More >>
(RTTNews) - Friday, British drug major GlaxoSmithKline Plc (GSK, GSK.L) said it has sold around 5.75 million shares of Madison, New Jersey-based diagnostic testing services provider Quest Diagnostics Inc. (DGX | Quote | Chart | News | PowerRating) since March 17 for about $256.14 million in Read More >>

UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.
TM News Letter Free News Letters
Free newsletters by the TradingMarkets editorial team.

Morning Coffee with TradingMarkets
Larry Connors Trading Lesson of the Day
7 Stocks You Need To Know For Tomorrow
TradingMarkets Weekly Newsletter
PowerRatings Newsletter
Most Overbought and Oversold ETFs
7 ETF's You Need to Know

Subscribe